Join the High Blood Pressure group to help and get support from people like you.
High Blood Pressure News (Page 10)
Related terms: Drug-Induced Hypertension, Primary Hypertension, Secondary Hypertension, Isolated Systolic Hypertension, Resistant Hypertension
Continual Cuffless BP Monitoring Can Classify Time-in-Target-Range Accurately
FRIDAY, July 12, 2024 – Continual cuffless blood pressure (BP) monitoring can classify time-in-target-range (TTR) accurately, according to a study published online June 26 in Frontiers in Medicine....
Proteomics Panel Not Useful for Predicting Hypertensive Disorders of Pregnancy
THURSDAY, July 11, 2024 – Large-scale proteomics in early pregnancy is not clinically useful for risk prediction of hypertensive disorders of pregnancy (HDP), according to a study published online...
FDA Medwatch Alert: Camber Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Valsartan Tablets, USP, 40mg, 80mg, 160mg and 320mg Due to The Detection of Trace Amounts of N-Nitrosodimethylamine (NDMA) Impurity, Found in an Active Pharmaceutical Ingredient (API)
As a precautionary measure, Camber Pharmaceuticals, Inc. is voluntarily recalling all unexpired lots of Valsartan Tablets, USP, 40mg, 80mg, 160mg and 320mg to the hospital, retail and consumer level....
FDA Medwatch Alert: Labetalol Hydrochloride Injection by Hospira: Recall - Potential For Cracked Glass At Rim Surface Of Vials
ISSUE: Hospira is voluntarily recalling 3 lots of Labetalol Hydrochloride Injection, USP, 100 mg/20 mL Vial (NDC 0409-2267-20), and one lot of Labetalol Hydrochloride Injection, USP, Novaplus (NDC...
Noden Pharma Announces FDA Approval of Tekturna (aliskiren) Oral Pellets for the Treatment of Hypertension in Adults and Children 6 Years of Age and Older
DUBLIN, Nov. 15, 2017 /PRNewswire/ – Noden Pharma DAC, a global specialty pharmaceutical company that is focused on acquiring prescription medicines across a broad range of therapeutic areas,...
FDA Approves Prestalia (amlodipine and perindopril) for Hypertension
CINCINNATI & BEND, Ore., January 26, 2015 --(BUSINESS WIRE)--Symplmed Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has approved Prestalia (perindopril arginine and...
FDA Medwatch Alert: Labetalol Hydrochloride Injection 100 MG/20 ML (5MG/ML), 20 ML, Multidose Vial by Hospira: Recall - Visible Particulates
ISSUE: Hospira, Inc. will initiate a voluntary nationwide recall to the user level for one lot of Labetalol Hydrochloride Injection, USP, 100 mg/20 mL (5 mg/mL) 20 mL Multidose Vial, NDC...
FDA Medwatch Alert: Olmesartan Medoxomil: Drug Safety Communication - Label Changes To Include Intestinal Problems (Sprue-Like Enteropathy)
ISSUE: FDA is warning that the blood pressure drug Olmesartan Medoxomil (marketed as Benicar, Benicar HCT, Azor, Tribenzor, and generics) can cause intestinal problems known as sprue-like...
FDA Medwatch Alert: Aliskiren-containing Medications: Drug Safety Comunication - New Warning and Contraindication
including: Amturnide (aliskiren hemifumarate, amlodipine besylate, and hydrochlorothiazide) Tekturna (aliskiren hemifumarate) Tekturna HCT (aliskiren hemifumarate and hydrochlorothiazide) Tekamlo...
FDA Approves Edarbi to Treat High Blood Pressure
ROCKVILLE, MD., Feb. 25, 2011--The U.S. Food and Drug Administration today approved Edarbi tablets (azilsartan medoxomil) to treat high blood pressure (hypertension) in adults. Data from clinical...
Further information
Related condition support groups
Cardiovascular Conditions and Disorders
Related drug support groups
lisinopril, metoprolol, amlodipine, propranolol, losartan, hydrochlorothiazide, atenolol, spironolactone, clonidine, view more... carvedilol, Metoprolol Succinate ER, diltiazem, Bystolic, Lasix, Metoprolol Tartrate, furosemide, bisoprolol, valsartan, Norvasc, ramipril, guanfacine, prazosin, verapamil, Benicar, Diovan, minoxidil, nifedipine, nitroglycerin, Coreg